Jason Fanning1, W Jack Rejeski1, Shyh-Huei Chen2, Jack Guralnik3, Marco Pahor4, Michael E Miller2. 1. Department of Health and Exercise Sciences, Wake Forest University, Winston-Salem, North Carolina. 2. Department of Biostatistical and Data Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina. 3. Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland. 4. Department of Aging and Geriatric Research, University of Florida, Gainesville, Florida.
Abstract
OBJECTIVES: To examine the relationship between time spent in light physical activity (LPA) and in moderate to vigorous physical activity (MVPA) and the pattern of accumulation on the risk for major mobility disability (MMD) in a large multicenter study of physical activity (PA) and aging, the Lifestyle Interventions and Independence for Elders (LIFE) study. DESIGN: Data were collected from individuals randomized to a PA intervention as part of the LIFE study, an eight-center single-blind randomized clinical trial conducted between February 2010 and December 2013. SETTING: Lifestyle Interventions and Independence for Elders Study PARTICIPANTS: Older adult participants (78.4 years; N = 507) at risk for MMD. INTERVENTION: All older adults included in these analyses were randomized to a structured PA intervention that included two center-based plus three to four home-based exercise sessions per week with a primary goal of walking for 150 minutes weekly. Participants attended the intervention for 2.5 years on average. MEASUREMENTS: MMD was defined as the inability to complete a 400-m walk within 15 minutes and without assistance. Physical function was assessed via the Short Physical Performance Battery (SPPB). Actigraph accelerometers were used to quantify amount and variability in LPA and MVPA. RESULTS: In an adjusted Cox proportional hazards regression, we identified a significant interaction (P = .017) between SPPB score and LPA amount and variability such that more LPA was associated with a reduced risk for MMD among those with higher initial function, as was lower variability (eg, via distributing LPA across the day). The SPPB × MVPA interaction was significant (P = .04), such that more MVPA was associated with lower MMD risk among those with lower function. Finally, greater MVPA variability was associated with lower risk for MMD. CONCLUSION: A prescription of PA for older adults should account for key factors such as physical function and emphasize both amount and pattern of accumulation of PA from across the intensity continuum. J Am Geriatr Soc 68:1476-1483, 2020.
RCT Entities:
OBJECTIVES: To examine the relationship between time spent in light physical activity (LPA) and in moderate to vigorous physical activity (MVPA) and the pattern of accumulation on the risk for major mobility disability (MMD) in a large multicenter study of physical activity (PA) and aging, the Lifestyle Interventions and Independence for Elders (LIFE) study. DESIGN: Data were collected from individuals randomized to a PA intervention as part of the LIFE study, an eight-center single-blind randomized clinical trial conducted between February 2010 and December 2013. SETTING: Lifestyle Interventions and Independence for Elders Study PARTICIPANTS: Older adult participants (78.4 years; N = 507) at risk for MMD. INTERVENTION: All older adults included in these analyses were randomized to a structured PA intervention that included two center-based plus three to four home-based exercise sessions per week with a primary goal of walking for 150 minutes weekly. Participants attended the intervention for 2.5 years on average. MEASUREMENTS: MMD was defined as the inability to complete a 400-m walk within 15 minutes and without assistance. Physical function was assessed via the Short Physical Performance Battery (SPPB). Actigraph accelerometers were used to quantify amount and variability in LPA and MVPA. RESULTS: In an adjusted Cox proportional hazards regression, we identified a significant interaction (P = .017) between SPPB score and LPA amount and variability such that more LPA was associated with a reduced risk for MMD among those with higher initial function, as was lower variability (eg, via distributing LPA across the day). The SPPB × MVPA interaction was significant (P = .04), such that more MVPA was associated with lower MMD risk among those with lower function. Finally, greater MVPA variability was associated with lower risk for MMD. CONCLUSION: A prescription of PA for older adults should account for key factors such as physical function and emphasize both amount and pattern of accumulation of PA from across the intensity continuum. J Am Geriatr Soc 68:1476-1483, 2020.
Authors: Marco Pahor; Jack M Guralnik; Walter T Ambrosius; Steven Blair; Denise E Bonds; Timothy S Church; Mark A Espeland; Roger A Fielding; Thomas M Gill; Erik J Groessl; Abby C King; Stephen B Kritchevsky; Todd M Manini; Mary M McDermott; Michael E Miller; Anne B Newman; W Jack Rejeski; Kaycee M Sink; Jeff D Williamson Journal: JAMA Date: 2014-06-18 Impact factor: 56.272
Authors: W Jack Rejeski; Peter H Brubaker; David C Goff; Lucille B Bearon; Jacquelyn W McClelland; Michael G Perri; Walter T Ambrosius Journal: Arch Intern Med Date: 2011-01-24
Authors: Mary M McDermott; Kiang Liu; Jack M Guralnik; Michael H Criqui; Bonnie Spring; Lu Tian; Kathryn Domanchuk; Luigi Ferrucci; Donald Lloyd-Jones; Melina Kibbe; Huimin Tao; Lihui Zhao; Yihua Liao; W Jack Rejeski Journal: JAMA Date: 2013-07-03 Impact factor: 56.272
Authors: S P Messier; R F Loeser; M N Mitchell; G Valle; T P Morgan; W J Rejeski; W H Ettinger Journal: J Am Geriatr Soc Date: 2000-09 Impact factor: 5.562
Authors: Anthony P Marsh; W Jack Rejeski; Mark A Espeland; Michael E Miller; Timothy S Church; Roger A Fielding; Thomas M Gill; Jack M Guralnik; Anne B Newman; Marco Pahor Journal: J Gerontol A Biol Sci Med Sci Date: 2011-10-05 Impact factor: 6.053
Authors: W Jack Rejeski; Robert Axtell; Roger Fielding; Jeffrey Katula; Abby C King; Todd M Manini; Anthony P Marsh; Marco Pahor; Alvito Rego; Catrine Tudor-Locke; Mark Newman; Michael P Walkup; Michael E Miller Journal: Clin Interv Aging Date: 2013-09-12 Impact factor: 4.458
Authors: Justin C Brown; Elizabeth Brighton; Nancy Campbell; Nadine J McCleary; Thomas A Abrams; James M Cleary; Peter C Enzinger; Kimmie Ng; Douglas Rubinson; Brian M Wolpin; Matthew B Yurgelun; Jeffrey A Meyerhardt Journal: BMJ Open Sport Exerc Med Date: 2022-05-30
Authors: Anna Picca; Sunil K Saini; Robert T Mankowski; George Kamenov; Stephen D Anton; Todd M Manini; Thomas W Buford; Stephanie E Wohlgemuth; Rui Xiao; Riccardo Calvani; Hélio José Coelho-Júnior; Francesco Landi; Roberto Bernabei; David A Hood; Emanuele Marzetti; Christiaan Leeuwenburgh Journal: Cells Date: 2020-12-02 Impact factor: 6.600
Authors: Andrea L Rosso; Ervin Sejdić; Anisha Suri; Jessie VanSwearingen; Pamela Dunlap; Mark S Redfern Journal: Aging Clin Exp Res Date: 2022-03-11 Impact factor: 4.481